Gothenburg is emerging as a leading location for health innovation and life sciences, driven by strong collaboration between healthcare, academia, the city, and industry. It hosts world-class research institutions like Sahlgrenska Academy and Chalmers University, and AstraZeneca's research center.
Effective collaboration between different professions is the cornerstone of exceptional research! We learn from history to make a better future, that is why collecting and processing data is such an important task. Performing statistical analyses is one thing, understanding it is another. APNC Sweden can help you design, understand and maximize the potential of your research data.
Innovator, entrepreneur, researcher and business developer - Mikael Kubista is a man with many talents and many roles. After building up one of the leading analysis and diagnostics businesses in the Gothenburg region, Kubista is now looking to expand his horizons further. His vision was always and will always be to improve quality of life for as many people as possible.
Neoss has revolutionised dental care with innovative solutions. Based on extensive research in Gothenburg, Neoss has successfully implemented simpler and more affordable solutions for dental implants using only one platform. Yet, all possible needs when it comes to dental implants are covered.
Vårt samhälle måste kunna fungera även vid olyckor, terrorattacker, pandemier eller krig och för att det ska fungera är vissa verksamheter viktigare än andra. Sjukvård är en sådan samhällsviktig verksamhet. Swecos arkitekter och teknikkonsulter utformar säkra och hållbara byggnader som är framtidssäkrade för allt från klimatförändringar till externa hot från andra nationer.
Enligt Genèvekonvent
The story of Trial Forum Support, TFS HealthScience, is a story of the ability to build a business entirely on customer needs. The impressive expansion from Skåne, Sweden, to the rest of the world has made TFS HealthScience a well-recognized and acclaimed CRO with a lot to offer any business wishing to conduct clinical trials in a most efficient and accurate way.
The recent introduction of the device NeoScan 2000 is the biggest happening for Neoss over the past years, ever since the initial launch of its predecessor NeoScan 1000. With NeoScan 1000 and now the improved and even smarter NeoScan 2000 it is possible to dramatically improve patient experience and at the same time gain better precision with the most affordable digital impressions solutions.
What do most Life Science companies have in common? What makes them thrive? There is a common need in almost all Life Science businesses, and that is the need to innovate and to translate those ideas into commercially viable treatments and products. Talent attracts talent and together they build innovative environments and promote growth. One such company well known for their contribution to suppo
The epigraph “Nobody should die waiting for a new organ” has always been a clear vision statement for XVIVO. The company has spent decades developing and perfecting unique and patented technologies and perfusion solutions for safe and efficient preservation, assessment and transportation of organs prior to a transplantation.
Medicines and treatments of the future will be developed using the patient’s own cells, to ensure a perfect match every time. In this context, a perfect match refers to the positive way in which the patient’s immune system responds to these tailored medicines, enabling for much more precise and effective treatments to a lot of diseases that are difficult to treat today.
A world-class innovation city for health is being built right now, close to Gothenburg city centre and therefore easily accessible to companies, researchers, financial institutions and other important stakeholders. GoCo Health Innovation City operates at the forefront of globally renowned research, it brings together the best talents in various disciplines, and it provides facilities for innovatio
Research and development about the role of the microbiome for human health is on the rise. From a European perspective the Medicon Valley region was a first mover, and, consequently, Medicon Valley Alliance and several member companies and stakeholders including the Technical University of Denmark, Lund University, University of Copenhagen and Novo Nordisk decided to both test the interest and adv
Medetect is a full-service contract research organisation (CRO) within histology with unique competence in immunopathology, computerised quantitative image analysis and histological research. The company has successfully contributed to crucial histology-based research in a vast number of projects in the pharmaceutical industry over the last 15 years.
ProPharma is the world’s first Research Consulting Organisation, RCO. With a global perspective, ProPharma offers a new degree of personalization and agility. The new RCO delivers a “3-D printed” solution for those sponsor programs and a personalized approach to drug and device development outsourcing.
Enbiosis has tamed the challenges of understanding and mapping the complexity of the human gut microbiome.
The gut and skin microbiome eco-systems are among the most complex setups in the world. By decoding and analysing them, it is possible to understand why some diseases are more developed in some individuals and not in others. More importantly, it is possible to present solutions to prevent the development of any disease in the first place.
The interest of developing therapies for diseases affecting the central nervous system, (CNS) has peaked recently. After the positive results from clinical studies testing two experimental drugs to treat Alzheimer’s disease, a lot of other research groups and companies have started to intensify their work within the field.
Everyone seems to be talking about gene therapy these days. Small, research-based companies seem to be born almost daily within the area, and they also seem to have a lot in common. A closer look will soon tell you that these companies are in fact all very different, and some are working on applications that are unique to them on a global basis. rAAVen Therapeutics is one of them.
Lundoch Diagnostics was founded by Dr Yang De Marinis in 2020. The company is widely known for the development and launch of the world’s first and only blood test technology to detect diabetes risk many years before diagnosis or any symptoms appear. This is the Holy Grail to promote better public health and wellbeing.
The Uppsala-based company, Mercodia, born out of a vibrant Life Science environment with a solid, long-standing reputation globally and especially throughout the Nordics as an immunoassay manufacturer and supplier, is now focusing on delivering bioanalytical services. The bioanalytical services are mainly directed toward pharma- and biotech companies and CROs in Europe and North America.
Vi är en rikstäckande affärstidning som startades 1982. Med aktuella teman och intressanta företagsreportage och annonser fungerar tidningen som en värdefull informationskälla för företag och offentlig sektor, som söker information om produkter och tjänster inom det svenska näringslivet
Box 2079
433 02 Sävedalen
Sverige